About DermTech
DermTech is a company based in San Diego (United States) founded in 1996 was acquired by Constellation Alpha in March 2019.. DermTech has raised $24.37 million across 6 funding rounds from investors including RTW Investments, Constellation Alpha and Jacob Hanoch. The company has 259 employees as of December 31, 2022. DermTech offers products and services including DermTech Melanoma Test and Smart Stickers. DermTech operates in a competitive market with competitors including Castle Biosciences, NeuMoDx, Molbio Diagnostics, Kryptos Biotechnologies and AMLo Biosciences, among others.
- Headquarter San Diego, United States
- Employees 259 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Dermtech, Llc
-
Annual Revenue
$15.3 M5as on Dec 31, 2023
-
Net Profit
$-100.89 M14as on Dec 31, 2023
-
EBITDA
$-103.74 M12as on Dec 31, 2023
-
Total Equity Funding
$24.37 M (USD)
in 6 rounds
-
Latest Funding Round
$65 M (USD), Post-IPO
Mar 13, 2020
-
Investors
RTW Investments
& 2 more
-
Employee Count
259
as on Dec 31, 2022
-
Acquired by
Constellation Alpha
(Mar 18, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DermTech
DermTech offers a comprehensive portfolio of products and services, including DermTech Melanoma Test and Smart Stickers. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive test to detect melanoma via genomic markers.
Adhesive devices for sample collection in skin lesion analysis.
Unlock access to complete
Unlock access to complete
Funding Insights of DermTech
DermTech has successfully raised a total of $24.37M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $65 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $65.0M
-
First Round
First Round
(10 Apr 2012)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2020 | Amount | Post-IPO - DermTech | Valuation |
investors |
|
| Feb, 2018 | Amount | Post-IPO - DermTech | Valuation |
investors |
|
| Nov, 2015 | Amount | Series B - DermTech | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in DermTech
DermTech has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include RTW Investments, Constellation Alpha and Jacob Hanoch. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life Sciences focused VC firm investing in the US
|
Founded Year | Domain | Location | |
|
JH
Jacob Hanoch |
-
|
Founded Year | Domain | Location |
|
Venture capital firm focused on innovative healthcare companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by DermTech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - DermTech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dermtech Comparisons
Competitors of DermTech
DermTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Castle Biosciences, NeuMoDx, Molbio Diagnostics, Kryptos Biotechnologies and AMLo Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
Developer of a platform for low cost molecular testing
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular platforms for infectious disease detection are developed.
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
|
|
| domain | founded_year | HQ Location |
Prognostic tests for early-stage melanoma detection are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Dermtech
Frequently Asked Questions about DermTech
When was DermTech founded?
DermTech was founded in 1996 and raised its 1st funding round 16 years after it was founded.
Where is DermTech located?
DermTech is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is DermTech a funded company?
DermTech is a funded company, having raised a total of $24.37M across 6 funding rounds to date. The company's 1st funding round was a Series B of $5M, raised on Apr 10, 2012.
How many employees does DermTech have?
As of Dec 31, 2022, the latest employee count at DermTech is 259.
What is the annual revenue of DermTech?
Annual revenue of DermTech is $15.3M as on Dec 31, 2023.
What does DermTech do?
DermTech was founded in 1996 in San Diego, United States. qPCR assays and diagnostic aids are developed for non-invasive analysis of skin samples to identify melanoma and other skin cancers. Cells from the outermost skin layer are captured using a proprietary adhesive patch applied directly to the patients skin. Gene expression levels in collected samples are then evaluated for diagnostic purposes in the dermatology sector.
Who are the top competitors of DermTech?
DermTech's top competitors include Molbio Diagnostics, NeuMoDx and AMLo Biosciences.
What products or services does DermTech offer?
DermTech offers DermTech Melanoma Test and Smart Stickers.
Who are DermTech's investors?
DermTech has 3 investors. Key investors include RTW Investments, Constellation Alpha, and Jacob Hanoch.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.